Stories from Darmstadt, Germany

16.02.2019 – 23:10
Merck KGaA
Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media - JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for ...
13.02.2019 – 14:53
Yanfeng Automotive Interiors
Yanfeng Automotive Interiors is honored with the Top Employer Award 2019 / YFAI is recognized as an employer of choice in Germany and Slovakia
12.02.2019 – 14:51
IFCO Systems
IFCO awards annual Sustainability Certificate to retailers and growers / Reinforces sustainability credentials of retailers and growers in North America and Europe
Pullach, Germany (ots) - IFCO, the leading global provider of reusable packaging solutions for fresh foods, is awarding its annual Sustainability Certificate in Europe and North America. IFCO's sustainability certification initiative was inaugurated in September 2018, when it was handed out to retailer customers in ...
11.02.2019 – 23:55
Merck KGaA
FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for BAVENCIO® (avelumab) in ...
06.02.2019 – 15:01
Merck KGaA
Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline
Darmstadt, Germany (ots/PRNewswire) - Not intended for US, Canada or UK-based media Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline - Merck investing $70 million in U.S. Research & Development Hub - Expansion of R&D footprint to accelerate science and innovation in Oncology, ...
05.02.2019 – 13:19
Merck KGaA
Merck and GSK Announce Global Alliance to Jointly Develop and Commercialize M7824, a Novel Immunotherapy with Potential in Multiple Difficult-to-Treat Cancers
Darmstadt, Germany (ots/PRNewswire) - Not intended for US, Canada or UK-based media - Eight high priority immuno-oncology clinical development studies ongoing or expected to commence in 2019, including studies in non-small cell lung and biliary tract cancers - Merck will receive an upfront payment of EUR300 million ...
05.02.2019 – 10:00
Jennewein Biotechnologie GmbH
Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market
Hohhot, China & Rheinbreitbach, Germany (ots) - - China represents the largest market for baby food globally - Human milk oligosaccharides are key for the development of a healthy infant microbiome Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO), ...
31.01.2019 – 11:00
Takko Fashion
Arnold Mattschull says goodbye from the operational management and joins the Takko Fashion advisory board / Change of management at Takko Fashion - Alexander Mattschull becomes new CEO of Takko Fashion
Telgte, Germany (ots) - Today Arnold Mattschull says goodbye to the operational management as CEO of the Smart Discounter Takko Fashion. Once the new business year begins on 1 February 2019, Alexander Mattschull will take over executive management of the company. Arnold Mattschull led the company for a total of over ...
24.01.2019 – 14:01
Merck KGaA
Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - Exclusive license grants Vertex one clinical and one pre-clinical DNA-PK inhibitor for use in gene-editing applications in six specific genetic disease areas - Merck retains the rights to both compounds in all other disease areas, including oncology - Merck retains the rights to utilize and ...
22.01.2019 – 10:28
IFCO Systems
IFCO advances digital services with global online RPCs management system and recollection app
Pullach, Germany (ots) - IFCO SYSTEMS presents new mobile MyIFCO(TM) recollect application for return logistics at Fruit Logistica IFCO SYSTEMS, the leading global provider of reusable packaging solutions, is further advancing its digital services with global online ordering and a new mobile application for return logistics. The new application, MyIFCO(TM) recollect, ...
16.01.2019 – 11:00
Lipotype
Lipotype announces "Lipidomics Excellence Award" for Breakthrough Lipidomics Projects / Call for Applications open till 30 March, 2019
Dresden/Germany (ots) - The international scientific community is called to submit applications for the premiere of the world's first award for cutting edge contributions to the progress of life sciences through lipidomics, the 2019 "Lipidomics Excellence Award" (LEA) until 30 March, 2019. Prof. Dr. Kai Simons, ...
21.12.2018 – 20:02
Merck KGaA
Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab* did not support the study's initial hypothesis, and therefore the ...
20.12.2018 – 19:07
G&G Biotechnology BV
POLYTECH Health & Aesthetics GmbH - Quality Made in Germany Pays Off: CE Approval For Breast Implants From One of the International Leading Companies Currently Confirmed
Dieburg, Germany (ots/PRNewswire) - On December 18, 2018, POLYTECH sold the three millionth implant since its establishment in 1986. The company is the only German manufacturer and present in over 75 countries worldwide. All implants are manufactured in the company's own production facilities in Dieburg near ...
20.12.2018 – 16:01
Merck KGaA
Merck Announces EMA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
Darmstadt, Germany (ots/PRNewswire) - The information contained is not intended for distribution in the USA, Canada or the UK - European Medicine Agency (EMA) grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer (BTC) - EMA orphan drug designation for M7824 in ...
20.12.2018 – 13:50
Merck KGaA
Merck Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
Darmstadt, Germany (ots/PRNewswire) - Not intended for distribution in the USA, Canada or UK - Agreement enables Merck to maintain an investment in the rapidly advancing oncology field of CAR-T, while focusing its R&D efforts - Intrexon to issue Merck $150 million of Intrexon stock and a $25 million convertible note; Intrexon to receive a $25 million cash investment ...
18.12.2018 – 11:00
Carl Zeiss AG
Another Record Year for ZEISS
Stuttgart, Germany (ots) - In fiscal year 2017/18 (ended on 30 September 2018), the company achieved record-breaking revenue and earnings The ZEISS Group is continuing its growth trajectory: Revenue increased by nine percent to EUR 5.817 billion (previous year: EUR 5.348 billion). After currency adjustments, revenue rose by 12 percent. With earnings, it was possible to fully compensate for the unfavorable currency effects. Thus, at EUR 772 million, earnings before interest ...
16.12.2018 – 15:00
UZE Mobility GmbH
German start-up: UZE Mobility buys 500 e-trucks for disrupting mobility business cases
14.12.2018 – 08:00
Grünenthal Group
Joint Press Release: Grünenthal and OnDosis team up for individualised dosing of oral drugs in pain management to increase patient safety
Aachen, Germany and Gothenburg, Sweden (ots) - - Grünenthal expands its portfolio with an innovative technology for individualised dosing - Life science startup OnDosis signs its first global development and licensing agreement for their innovative technology Grünenthal and OnDosis announced today that they have ...
13.12.2018 – 15:00
meyerschmitzmorkramer
International architecture award for the Michaelsberg Abbey, Germany, by meyerschmitzmorkramer
13.12.2018 – 09:30
TIME & HISTORY
Führerbunker VR - Experience the End of the Third Reich in Hitler's Last Hideout
Hannover, Germany (ots) - - Historically authentic VR reconstruction of the so-called Führerbunker - Kick-off project of Time & History (https://TimeAndHistory.com), a VR documentary series - Developed by German VR studio NORD/VR Funded by nordmedia - Film- und Mediengesellschaft Niedersachsen/Bremen mbH VR developer NORD/VR creates an authentic reconstruction of the ...
10.12.2018 – 16:21
Merck KGaA
Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
Darmstadt, Germany (ots/PRNewswire) - The information contained is not intended for distribution in the USA, Canada or the UK - FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of ...
06.12.2018 – 14:01
Merck KGaA
Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities
Darmstadt, Germany (ots/PRNewswire) - Not intended for distribution in the USA, Canada or UK - Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological ...
03.12.2018 – 09:56
Grünenthal Gruppe
Grünenthal closes deal with AstraZeneca for Nexium and Vimovo
Aachen, Germany (ots) - Grünenthal today announced the successful completion of its acquisition of European rights to Nexium and global (ex US and Japan) rights to Vimovo from AstraZeneca for a total consideration of up to US$ 922 m (EUR 811 m). "Today is an important day for Grünenthal," said Gabriel Baertschi, CEO Grünenthal. "This transaction represents a significant step towards our vision of creating a world free ...
19.11.2018 – 13:08
Merck KGaA
Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared ...
19.11.2018 – 11:07
commercetools
commercetools Named a Major Player in 2018 IDC MarketScape for B2C Digital Commerce
Munich (Germany) (ots) - API-first Architecture and Fast Deployment Cited Among Top Strengths commercetools, a global leader in next-generation commerce software, has been positioned in the Major Players category of the 2018 IDC MarketScape for B2C Digital Commerce report, which aims to help organizations manage the "speed of change in B2C digital commerce." ...
14.11.2018 – 08:45
Grünenthal Group
Grünenthal acquires Averitas Pharma and establishes commercial footprint in the US
Aachen, Germany / Morristown, New Jersey, USA (ots) - Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza® (8 % capsaicin) for Grünenthal in the US. Grünenthal had only recently acquired the ...
06.11.2018 – 14:47
IFCO Systems
Study: IFCO RPCs extend shelf life of fresh produce by up to 4 days
Pullach, Germany (ots) - IFCO, the leading global provider of reusable packaging solutions for fresh foods, announced today the results of a study (https://www.ifco.com/000f855f4e852d8f) on the impact of IFCO reusable plastic containers (RPCs) on the shelf life of fresh produce. IFCO RPCs extend the freshness and visual appeal of fresh fruits and vegetables for up to four days compared to single-use packaging. The study ...

12345678910Next